Establishment of a paclitaxel resistant human breast cancer cell strain (MCF-7/Taxol) and intracellular paclitaxel binding protein analysis

J Int Med Res. 2010 Jul-Aug;38(4):1428-35. doi: 10.1177/147323001003800424.

Abstract

Multidrug resistance of tumours is one of the most important factors that leads to chemotherapy failure. A multidrug-resistant breast cancer cell line, MCF-7/Taxol, was established from the drug-sensitive parent cell line MCF-7. The biological properties of MCF-7/Taxol, including its drug resistance profile and profile of paclitaxel binding proteins, were analysed and compared with the parent cell line. A number of paclitaxel binding proteins were present in MCF-7 cells but absent from MCF-7/Taxol cells, namely heat shock protein 90, actinin and dermcidin precursor. The identification of differential paclitaxel binding proteins between the multidrug-resistant MCF-7/Taxol cell line and the parent drug-sensitive cell line MCF-7 provides insight into possible mechanisms involved in resistance to these chemotherapy drugs.

MeSH terms

  • Biotinylation / drug effects
  • Blotting, Western
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Carrier Proteins / isolation & purification
  • Carrier Proteins / metabolism*
  • Cell Culture Techniques / methods*
  • Cell Line, Tumor
  • Chromatography, Liquid
  • Drug Resistance, Multiple / drug effects
  • Drug Resistance, Neoplasm / drug effects*
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Humans
  • Intracellular Space / metabolism*
  • Mass Spectrometry
  • Paclitaxel / chemistry
  • Paclitaxel / pharmacology*
  • Paclitaxel / therapeutic use*
  • Protein Binding / drug effects
  • Silver Staining

Substances

  • Carrier Proteins
  • Paclitaxel